Stocks
GlaxoSmithKline (GSK) Net debt US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Net debt, £ | 26 869 579 100 | 13 110 000 000 | 16 363 332 800 | 13 272 000 000 | 14 288 841 000 | 20 588 863 000 | |||
| Changes by years, y/y, % | -5% | -51% | +25% | -19% | +8% | -12.8% | |||
GlaxoSmithKline. Net debt, £
GlaxoSmithKline. Net debt, changes, %
GlaxoSmithKline (GSK) Net debt US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Net debt, £ | 18 821 757 000 | 19 445 235 000 | 14 288 841 000 | 14 288 841 000 | 20 588 863 000 | 20 588 863 000 | ||
| Changes by years, y/y, % | +7% | +51% | +8% | +8% | +14% | |||
| Changes by quarters, q/q, % | +5% | +3% | -27% | 0% | +44% | |||
